Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Biomed Pharmacother ; 176: 116887, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38852511

ABSTRACT

BACKGROUND: The metastasis of tumors into bone tissue typically leads to intractable pain that is both very disabling and particularly difficult to manage. We investigated here whether riluzole could have beneficial effects for the treatment of prostate cancer-induced bone pain and how it could influence the development of bone metastasis. METHODS: We used a bone pain model induced by intratibial injection of human PC3 prostate cancer cells into male SCID mice treated or not with riluzole administered in drinking water. We also used riluzole in vitro to assess its possible effect on PC3 cell viability and functionality, using patch-clamp. RESULTS: Riluzole had a significant preventive effect on both evoked and spontaneous pain involving the TREK-1 potassium channel. Riluzole did not interfere with PC3-induced bone loss or bone remodeling in vivo. It also significantly decreased PC3 cell viability in vitro. The antiproliferative effect of riluzole is correlated with a TREK-1-dependent membrane hyperpolarization in these cells. CONCLUSION: The present data suggest that riluzole could be very useful to manage evoked and spontaneous hypersensitivity in cancer-induced bone pain and has no significant adverse effect on cancer progression.


Subject(s)
Analgesics , Bone Neoplasms , Cancer Pain , Cell Proliferation , Mice, SCID , Potassium Channels, Tandem Pore Domain , Riluzole , Riluzole/pharmacology , Animals , Potassium Channels, Tandem Pore Domain/metabolism , Male , Bone Neoplasms/drug therapy , Bone Neoplasms/metabolism , Bone Neoplasms/secondary , Bone Neoplasms/pathology , Bone Neoplasms/complications , Humans , Cancer Pain/drug therapy , Cancer Pain/metabolism , Analgesics/pharmacology , Cell Proliferation/drug effects , PC-3 Cells , Mice , Cell Survival/drug effects , Prostatic Neoplasms/drug therapy , Prostatic Neoplasms/pathology , Prostatic Neoplasms/metabolism , Cell Line, Tumor
2.
Nutrients ; 12(3)2020 Mar 24.
Article in English | MEDLINE | ID: mdl-32214021

ABSTRACT

Retinal pigment epithelial cells are crucial for retina maintenance, making their cytoprotection an excellent way to prevent or slow down retinal degeneration. In addition, oxidative stress, inflammation, apoptosis, neovascularization, and/or autophagy are key pathways involved in degenerative mechanisms. Therefore, here we studied the effects of curcumin, lutein, and/or resveratrol on human retinal pigment epithelial cells (ARPE-19). Cells were incubated with individual or combined agent(s) before induction of (a) H2O2-induced oxidative stress, (b) staurosporin-induced apoptosis, (c) CoCl2-induced hypoxia, or (d) a LED-autophagy perturbator. Metabolic activity, cellular survival, caspase 3/7 activity (casp3/7), cell morphology, VEGF levels, and autophagy process were assessed. H2O2 provoked a reduction in cell survival, whereas curcumin reduced metabolic activity which was not associated with cell death. Cell death induced by H2O2 was significantly reduced after pre-treatment with curcumin and lutein, but not resveratrol. Staurosporin increased caspase-3/7 activity (689%) and decreased cell survival by 32%. Curcumin or lutein protected cells from death induced by staurosporin. Curcumin, lutein, and resveratrol were ineffective on the increase of caspase 3/7 induced by staurosporin. Pre-treatment with curcumin or lutein prevented LED-induced blockage of autophagy flux. Basal-VEGF release was significantly reduced by lutein. Therefore, lutein and curcumin showed beneficial protective effects on human-derived retinal cells against several insults.


Subject(s)
Biological Products/pharmacology , Plant Extracts/chemistry , Protective Agents/pharmacology , Retina/cytology , Retina/drug effects , Vegetables/chemistry , Apoptosis/drug effects , Autophagy/drug effects , Biological Products/chemistry , Cell Survival/drug effects , Cells, Cultured , Cytoprotection/drug effects , Dose-Response Relationship, Drug , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Humans , Oxidative Stress/drug effects , Protective Agents/chemistry , Reactive Oxygen Species/metabolism , Retinal Pigment Epithelium/cytology , Retinal Pigment Epithelium/drug effects
3.
PLoS One ; 10(6): e0128395, 2015.
Article in English | MEDLINE | ID: mdl-26042773

ABSTRACT

In the present study, we have evaluated one of the dietary supplements enriched with antioxidants and fish oil used in clinical care for patient with age-related macular degeneration. Rats were orally fed by a gastric canula daily with 0.2 ml of water or dietary supplement until they were sacrificed. After one week of treatment, animals were either sacrificed for lipid analysis in plasma and retina, or used for evaluation of rod-response recovery by electroretinography (ERG) followed by their sacrifice to measure rhodopsin content, or used for progressive light-induced retinal degeneration (PLIRD). For PLIRD, animals were transferred to bright cyclic light for one week. Retinal damage was quantified by ERG, histology and detection of apoptotic nuclei. Animals kept in dim-cyclic-light were processed in parallel. PLIRD induced a thinning of the outer nuclear layer and a reduction of the b-wave amplitude of the ERG in the water group. Retinal structure and function were preserved in supplemented animals. Supplement induced a significant increase in omega-3 fatty acids in plasma by 168% for eicosapentaenoic acid (EPA), 142% for docosapentaenoic acid (DPA) and 19% for docosahexaenoic acid (DHA) and a decrease in the omega-6 fatty acids, DPA by 28%. In the retina, supplement induced significant reduction of linolenic acid by 67% and an increase in EPA and DPA by 80% and 72%, respectively, associated with significant decrease in omega-6 DPA by 42%. Supplement did not affect rhodopsin content or rod-response recovery. The present data indicate that supplement rapidly modified the fatty acid content and induced an accumulation of EPA in the retina without affecting rhodopsin content or recovery. In addition, it protected the retina from oxidative stress induced by light. Therefore, this supplement might be beneficial to slow down progression of certain retinal degeneration.


Subject(s)
Antioxidants/therapeutic use , Dietary Supplements , Disease Progression , Fatty Acids, Omega-3/therapeutic use , Light/adverse effects , Retinal Degeneration/pathology , Retinal Degeneration/prevention & control , Animals , Apoptosis/radiation effects , Biosynthetic Pathways/radiation effects , Electroretinography , Fatty Acids, Omega-3/blood , Fatty Acids, Omega-6/blood , Female , Male , Neuroprotective Agents/therapeutic use , Plasmalogens/metabolism , Rats, Sprague-Dawley , Regeneration/radiation effects , Retina/pathology , Retina/radiation effects , Retinal Degeneration/blood , Retinal Rod Photoreceptor Cells/pathology , Retinal Rod Photoreceptor Cells/radiation effects , Rhodopsin/metabolism
4.
PLoS One ; 9(8): e105996, 2014.
Article in English | MEDLINE | ID: mdl-25153086

ABSTRACT

Visual sensory impairments are common in Mental Deficiency (MD) and Autism Spectrum Disorder (ASD). These defects are linked to cerebral dysfunction in the visual cortical area characterized by the deregulation of axon growth/guidance and dendrite spine immaturity of neurons. However, visual perception had not been addressed, although the retina is part of the central nervous system with a common embryonic origin. Therefore, we investigated retinal perception, the first event of vision, in a murine model of MD with autistic features. We document that retinal function is altered in Fmr1 KO mice, a model of human Fragile X Syndrome. Indeed, In Fmr1 KO mice had a lower retinal function characterized by a decreased photoreceptors neuron response, due to a 40% decrease in Rhodopsin content and to Rod Outer Segment destabilization. In addition, we observed an alteration of the visual signal transmission between photoreceptors and the inner retina which could be attributed to deregulations of pre- and post- synaptic proteins resulting in retinal neurons synaptic destabilization and to retinal neurons immaturity. Thus, for the first time, we demonstrated that retinal perception is altered in a murine model of MD with autistic features and that there are strong similarities between cerebral and retinal cellular and molecular defects. Our results suggest that both visual perception and integration must be taken into account in assessing visual sensory impairments in MD and ASD.


Subject(s)
Fragile X Mental Retardation Protein/genetics , Fragile X Syndrome/physiopathology , Retina/physiopathology , Rhodopsin/genetics , Visual Perception/physiology , Animals , Disease Models, Animal , Fragile X Syndrome/genetics , Fragile X Syndrome/metabolism , Male , Mice , Mice, Knockout , Phenotype , Retina/metabolism , Rhodopsin/metabolism
5.
Bioorg Med Chem Lett ; 20(24): 7405-9, 2010 Dec 15.
Article in English | MEDLINE | ID: mdl-21071218

ABSTRACT

Two cholesterol-based α-phenyl-N-tert-butyl nitrone derivatives were synthesized as antioxidants against light-induced retinal degeneration. Whereas nitrone 10 significantly protected retina against bright fluorescent light exposure when injected into the vitreous at 1 mM, no protection was observed with nitrone 6. The parent compound α-phenyl-N-tert-butyl nitrone also exhibited protective activity at 9 mM but not at 1 mM. This suggests that nitrone 10 may be a candidate for the treatment of retinal diseases.


Subject(s)
Antioxidants/chemistry , Cholesterol/analogs & derivatives , Cholesterol/chemistry , Cyclic N-Oxides/chemistry , Disaccharides/chemistry , Imines/chemistry , Light , Retinal Degeneration/prevention & control , Animals , Antioxidants/chemical synthesis , Antioxidants/therapeutic use , Cholesterol/chemical synthesis , Cholesterol/therapeutic use , Cyclic N-Oxides/chemical synthesis , Cyclic N-Oxides/therapeutic use , Disaccharides/chemical synthesis , Disaccharides/therapeutic use , Imines/chemical synthesis , Imines/therapeutic use , Rats , Reactive Oxygen Species/metabolism , Retinal Diseases/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...